Bioluminescence Ventures
Angela Ni is a professional in healthcare venture capital, currently working at Bioluminescence Ventures since 2022, focusing on therapeutics, medtech, and tech bio from Series A to C. Prior experience includes a position in healthcare investment banking at Goldman Sachs from 2021 to 2022 and biotech investment research at Evercore from 2019 to 2021, specifically on the SMID-Cap Biotech team. Angela Ni holds a dual degree in Biophysics and Economics (Finance) from The Wharton School, under the Roy & Diana Vagelos Program in Life Sciences & Management.
This person is not in any teams
This person is not in any offices
Bioluminescence Ventures
Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine. We are inspired by the accelerating pace of biomedical innovation and its recent impact on humanity. We are mission-driven – investing our time, energy, and capital into translating transformative science into next-generation medicines that will impact patients. We believe that, as long as we continue to succeed in this endeavor, then strong financial returns will follow. The firm focuses investments on four areas: Breakthrough Biology, Drug Discovery Platforms, Genetic Medicines Platforms, and Computational Biology Platforms.